HRTX

0.8833

2.85% 0.0245

시간 외 거래: .88 -0.0033 -0.37%

Heron Therapeutics Inc (HRTX)

개요 뉴스 가격 이력 옵션 체인 Financials HRTX 왜 하락? 토론 예측 주식 분할

전일 마감가:

$0.8588

열려 있는:

$0.8585

하루 거래량:

1.61M

Relative Volume:

0.72

시가총액:

$167.19M

수익:

$154.90M

순이익/손실:

$-20.20M

주가수익비율:

-7.3303

EPS:

-0.1205

순현금흐름:

$-27.91M

1주 성능:

+4.15%

1개월 성능:

-25.77%

6개월 성능:

-21.13%

1년 성능:

-52.25%

1일 변동 폭

$0.8415

$0.8896

1주일 범위

$0.8336

$0.8953

52주 변동 폭

$0.7362

$2.30

Heron Therapeutics Inc Stock (HRTX) Company Profile

명칭

Heron Therapeutics Inc

부문

Healthcare (1111)

산업

Biotechnology (621)

전화

(858) 251-4400

주소

4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA

직원

122

트위터

다음 수익 날짜

2026-05-11

최신 SEC 제출 서류

HRTX's Discussions on Twitter

Compare HRTX vs VRTX, REGN, ARGX, ALNY, RVMD

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
HRTX Heron Therapeutics Inc	0.8833	162.55M	154.90M	-20.20M	-27.91M	-0.1205
VRTX Vertex Pharmaceuticals Inc	435.93	110.28B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	634.62	66.98B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	808.43	50.15B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	295.50	39.71B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	154.89	32.22B	742.00K	-1.37B	-1.07B	-7.0731

Heron Therapeutics Inc Stock (HRTX) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2025-06-09	개시	H.C. Wainwright	Buy
2024-06-13	개시	Rodman & Renshaw	Buy
2024-04-23	개시	CapitalOne	Overweight
2024-03-13	재확인	Needham	Buy
2020-05-27	개시	Guggenheim	Buy
2020-02-20	재확인	Needham	Buy
2019-01-16	재확인	Needham	Buy
2018-04-05	개시	Evercore ISI	Outperform
2018-03-19	재확인	Mizuho	Buy
2018-03-01	재확인	Needham	Buy
2018-01-03	개시	Leerink Partners	Outperform
2017-09-27	개시	Northland Capital	Outperform
2017-02-27	개시	Needham	Buy
2016-10-26	개시	Aegis Capital	Buy
2016-09-06	재개	Lake Street	Buy
2016-05-03	개시	Cantor Fitzgerald	Buy
2015-12-10	개시	Lake Street	Buy
2015-09-23	재확인	Leerink Partners	Outperform
2015-09-02	개시	BofA/Merrill	Buy
2015-08-03	재확인	Brean Capital	Buy
2015-06-30	재확인	JMP Securities	Mkt Outperform
2015-06-19	재확인	Leerink Partners	Outperform
2014-08-07	개시	Noble Financial	Buy

모두보기

Heron Therapeutics Inc 주식(HRTX)의 최신 뉴스

May 25, 2026

HRTX PE Ratio & Valuation, Is HRTX Overvalued - Intellectia AI

May 25, 2026

May 24, 2026

Acute care revenue growth helps Heron (HRTX) reaffirm 2026 guidance despite Q1 sales decline - MSN

May 24, 2026

May 19, 2026

Why Heron Therapeutics, Inc. (HRTX) Price Target Was Reduced to $4 at H.C. Wainwright? - Insider Monkey

May 19, 2026

May 18, 2026

Heron Therapeutics (HRTX) price target decreased by 15.38% to 3.74 - MSN

May 18, 2026

May 16, 2026

Heron Therapeutics, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:HRTX) 2026-05-16 - Seeking Alpha

May 16, 2026

May 15, 2026

HRTX Stock Price, Quote & Chart | HERON THERAPEUTICS INC (NASDAQ:HRTX) - ChartMill

May 15, 2026

May 13, 2026

Heron outlines $173M-$183M 2026 net product sales outlook as it targets return to positive adjusted EBITDA - MSN

May 13, 2026

Adage Capital amendment shows 0% ownership in Heron Therapeutics (HRTX) - Stock Titan

May 13, 2026

Heron Therapeutics (HRTX) Quarterly Loss Revives Dilution Fears And Tests Profitability Narrative - Sahm

May 13, 2026

May 12, 2026

H.C. Wainwright Maintains Heron Therapeutics(HRTX.US) With Buy Rating, Maintains Target Price $4 - Moomoo

May 12, 2026

Heron Therapeutics | 10-Q: Q1 2026 Earnings Report - Moomoo

May 12, 2026

Heron Therapeutics, Inc. (NASDAQ:HRTX) Q1 2026 Earnings Call Transcript - Insider Monkey

May 12, 2026

H.C. Wainwright Maintains Heron Therapeutics(HRTX.US) With Buy Rating, Cuts Target Price to $4 - Moomoo

May 12, 2026

Needham Maintains Heron Therapeutics(HRTX.US) With Buy Rating, Maintains Target Price $3 - Moomoo

May 12, 2026

H.C. Wainwright cuts Heron Therapeutics stock price target on weak Q1 results - Investing.com

May 12, 2026